Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,807 | 62,835 | 58,761 | 77,418 | 37,844 |
| Marketable Securities | 96,659 | 129,419 | 111,410 | 105,527 | 125,402 |
| Receivables | 94,898 | 95,540 | 98,229 | 103,337 | 121,647 |
| Inventories | 103,645 | 95,400 | 91,834 | 112,447 | 98,682 |
| Other current assets | 0 | 0 | 0 | 0 | 1,427 |
| TOTAL | $360,610 | $388,445 | $365,115 | $401,296 | $386,794 |
| Non-Current Assets | |||||
| PPE Net | 21,487 | 21,547 | 17,859 | 20,455 | 20,079 |
| Investments And Advances | 110,930 | 105,819 | 120,023 | 129,340 | 139,258 |
| Intangibles | 380,152 | 376,239 | 369,804 | 397,084 | 404,376 |
| Other Non-Current Assets | 72,185 | 76,155 | 72,692 | 62,974 | 63,236 |
| TOTAL | $584,754 | $579,760 | $580,378 | $609,853 | $626,949 |
| Total Assets | $945,364 | $968,205 | $945,493 | $1,011,149 | $1,013,743 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,988 | 19,316 | 17,850 | 25,684 | 21,097 |
| Accounts payable and accrued liabilities | 77,808 | 86,034 | 85,366 | 82,782 | 93,537 |
| Other current liabilities | 1,801 | 1,646 | 1,046 | 1,515 | 1,545 |
| TOTAL | $105,829 | $116,485 | $114,029 | $115,077 | $121,995 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,964 | 42,925 | 44,016 | 49,680 | 51,364 |
| Other Non-Current Liabilities | 33,235 | 37,322 | 32,263 | 21,941 | 23,539 |
| TOTAL | $76,734 | $89,831 | $84,593 | $81,407 | $84,549 |
| Total Liabilities | $182,563 | $206,316 | $198,622 | $196,484 | $206,544 |
| Shareholders' Equity | |||||
| Common Shares | 540,945 | 540,134 | 540,046 | 560,500 | 571,928 |
| Retained earnings | 144,257 | 146,342 | 150,888 | 173,735 | 162,449 |
| Other shareholders' equity | 51,937 | 48,912 | 29,946 | 54,806 | 47,547 |
| TOTAL | $762,801 | $761,889 | $746,871 | $814,665 | $807,199 |
| Total Liabilities And Equity | $945,364 | $968,205 | $945,493 | $1,011,149 | $1,013,743 |